Although pravastatin is widely used to treat hypercholesterolemia, several other statin molecules have previously demonstrated anti-cancer effects via HDAC inhibition (Vigushin et al. 2001, Shen et al. 2020). Here, HDAC9 is linked to familial hypercholesterolemia.